Platinum(II)-ammonium chloride structure
|
Common Name | Platinum(II)-ammonium chloride | ||
|---|---|---|---|---|
| CAS Number | 13820-41-2 | Molecular Weight | 372.96700 | |
| Density | 2.936 g/mL at 25 °C(lit.) | Boiling Point | N/A | |
| Molecular Formula | H8Cl4N2Pt | Melting Point | 140 °C (dec.)(lit.) | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS05, GHS06, GHS08 |
Signal Word | Danger | |
| Name | ammonium tetrachloroplatinate |
|---|---|
| Synonym | More Synonyms |
| Density | 2.936 g/mL at 25 °C(lit.) |
|---|---|
| Melting Point | 140 °C (dec.)(lit.) |
| Molecular Formula | H8Cl4N2Pt |
| Molecular Weight | 372.96700 |
| Exact Mass | 370.90900 |
| LogP | 3.50790 |
| Water Solubility | Soluble |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS05, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H301-H315-H317-H318-H334 |
| Precautionary Statements | P261-P280-P301 + P310-P305 + P351 + P338-P342 + P311 |
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
| Hazard Codes | T:Toxic; |
| Risk Phrases | R25;R28;R41;R42/43 |
| Safety Phrases | S22-S26-S36/37/39-S45 |
| RIDADR | 3288 |
| WGK Germany | 1 |
| RTECS | TP1840000 |
| Packaging Group | III |
| Hazard Class | 6.1(b) |
|
Platinum complexes and pyruvate kinase activity.
Gen. Physiol. Biophys. 17(1) , 25-36, (1998) The interaction of platinum complexes with bovine heart pyruvate kinase (PK) was studied by absorption, CD, fluorescence spectroscopy and enzymic activity test. Our results showed that activity of PK ... |
|
|
Optimization of the efficiency of cross-linking PtII oligonucleotide phosphorothioate complexes to complementary oligonucleotides.
Nucleic Acids Res. 18(17) , 5163-71, (1990) We have investigated the efficiency with which PtII complexes cross-link phosphorothioates of oligonucleotides to complementary DNA targets. The A and G residues 2-5 bases downstream from the 5'-phosp... |
|
|
Hyperthermia and platinum complexes: time between treatments and synergy in vitro and in vivo.
Int. J. Hyperthermia 11(4) , 575-86, (1995) To investigate the greatest therapeutic efficacy, we investigated the effect of scheduling on the cytotoxic interaction between hyperthermia and seven different platinum complexes in vitro and in vivo... |
| diammonium tetrachloroplatinate |
| Diammonium tetrachloroplatinate(2-) |
| Ammonium platinous chloride |
| Ammonium tetrachloroplatinate |
| EINECS 237-499-1 |
| Diammonium tetrachloroplatinate (2-) |
| AMMONIUM CHLOROPLATINITE |
| Platinate(2-), tetrachloro-, ammonium (1:2) |
| AMMONIUMTETRACHLOROPLATINITE |
| Platinum(II)-ammonium chloride |
| Platinate (2-), tetrachloro-, diammonium |
| PLATINUM AMMONIUM CHLORIDE |
| MFCD00010885 |
| AMMONIUM PLATINUM CHLORIDE |
| Ammonium tetrachloroplatinate(II) |
| Ammonium tetrachloroplatinate(II),(trace metal basis) |